Paper Details 
Original Abstract of the Article :
Clobazam (CLB) was approved in October 2011 by the United States FDA as an adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients older than the age of 2. Due to its unique chemical design and selective binding to the alpha-2 GABA-receptor, CLB has...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720012/

データ提供:米国国立医学図書館(NLM)

Clobazam and Aspiration Pneumonia: A Desert of Unexpected Challenges

This study explores a hidden danger in the desert of epilepsy treatment: clobazam-induced aspiration pneumonia. The authors, like vigilant desert explorers, uncover a potential complication associated with [treatment], highlighting the need for increased awareness and proactive measures to prevent this serious condition. The authors utilized a [research method] approach to investigate this unexpected finding, offering valuable insights for clinicians treating patients with epilepsy.

A Hidden Oasis of Risk

The study revealed [key findings], highlighting a previously under-recognized risk associated with clobazam therapy. These findings underscore the importance of vigilance and proactive measures to prevent this potentially serious complication.

A Desert Oasis of Safety

This research emphasizes the importance of [recommendations for action] to mitigate the risk of aspiration pneumonia in patients receiving clobazam therapy. It's like finding a hidden oasis in the desert, offering a safe haven from the dangers of this potential complication and providing valuable guidance for ensuring the safety and well-being of patients with epilepsy.

Dr.Camel's Conclusion

While clobazam can be a valuable treatment for epilepsy, this study serves as a reminder of the potential for unexpected complications. It highlights the importance of careful monitoring, proactive measures, and increased awareness among clinicians to ensure the safety and well-being of patients receiving this medication. It's like a hidden oasis of safety in the vast desert of epilepsy treatment, reminding us that even in familiar territory, there can be hidden dangers that we must be aware of.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-12-16
Further Info :

Pubmed ID

33313501

DOI: Digital Object Identifier

PMC7720012

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.